(Q36645472)

15 August 2017

1 reference

title

Pharmacogenetics of beta2-agonist drugs in asthma (English)

1 reference

15 August 2017

1 reference

1

D Robin Taylor

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Clinical Reviews in Allergy & Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

31

1 reference

15 August 2017

issue

2-3

1 reference

15 August 2017

page(s)

247-258

1 reference

https://scigraph.springernature.com/pub.10.1385/criai:31:2:247

15 August 2017

exact match

0 references

cites work

Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy

1 reference

12 December 2020

Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene.

1 reference

12 December 2020

Coding block and 5 leader cistron polymorphisms of the beta2-adrenergic receptor

1 reference

12 December 2020

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

1 reference

12 December 2020

Some observations on a new syndrome--respiratory medicamentosa

1 reference

12 December 2020

Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma

1 reference

12 December 2020

Polymorphisms of the beta2-adrenergic receptor and asthma

1 reference

12 December 2020

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

1 reference

12 December 2020

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

1 reference

12 December 2020

The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology

1 reference

12 December 2020

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

1 reference

12 December 2020

Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations

1 reference

12 December 2020

Inflammatory mediators of asthma: an update

1 reference

12 December 2020

Asthma induced by adrenergic aerosols

1 reference

12 December 2020

Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression

1 reference

12 December 2020

Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells.

1 reference

12 December 2020

Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions

1 reference

12 December 2020

The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization

1 reference

12 December 2020

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

1 reference

12 December 2020

beta-Adrenoceptor polymorphisms: focus moves to long-acting beta-agonists

1 reference

12 December 2020

Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals.

1 reference

12 December 2020

beta-Adrenergic receptor polymorphisms and response to salmeterol

1 reference

12 December 2020

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

1 reference

12 December 2020

The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).

1 reference

12 December 2020

Cytokine regulation of beta-adrenergic responses in airway smooth muscle

1 reference

12 December 2020

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma

1 reference

12 December 2020

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

1 reference

12 December 2020

beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians

1 reference

12 December 2020

Pharmacology and physiology of human adrenergic receptor polymorphisms

1 reference

12 December 2020

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

1 reference

12 December 2020

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

12 December 2020

The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis

1 reference

12 December 2020

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

1 reference

12 December 2020

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

1 reference

12 December 2020

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

1 reference

12 December 2020

Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans.

1 reference

12 December 2020

Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness

1 reference

12 December 2020

Polymorphism of the beta(2)-adrenergic receptor gene and desensitization in human airway smooth muscle

1 reference

12 December 2020

The use of beta-agonists and the risk of death and near death from asthma

1 reference

12 December 2020

Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells

1 reference

12 December 2020

Primary structure of the human beta-adrenergic receptor gene

1 reference

12 December 2020

beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals.

1 reference

12 December 2020

Implications of genetic variability of human beta 2-adrenergic receptor structure

1 reference

12 December 2020

Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients

1 reference

12 December 2020

Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma

1 reference

12 December 2020

Beta2-adrenergic receptor genotype-related changes in cAMP levels in peripheral blood mononuclear cells after multiple-dose oral procaterol

1 reference

12 December 2020

Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects

1 reference

12 December 2020

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

1 reference

12 December 2020

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

1 reference

12 December 2020

Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline

1 reference

12 December 2020

Effect of IL-1 beta on responses of cultured human airway smooth muscle cells to bronchodilator agonists

1 reference

12 December 2020

A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:31:2:247

1 reference

Dimensions Publication ID

15 August 2017

1050429223

0 references

1 reference